Michael Kemp

Michael Kemp is a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen, Faculty of Health and Medical Sciences. His research is centered on clinical microbiology with a strong emphasis on antibiotic resistance mechanisms and bacterial pathogenesis.

Professor Kemp's research spans the fields of antibiotic resistance, clinical microbiology, and infectious diseases. He investigates genetic variations in resistance genes (such as blaZ in Staphylococcus aureus), genomic epidemiology of resistant pathogens (like vancomycin-resistant Enterococcus faecium), and the role of host factors in bacterial invasion (e.g., Listeria monocytogenes). His work combines molecular biology, genomics, and clinical studies to address critical challenges in antimicrobial resistance.

His recent publications (2025) demonstrate a focus on cutting-edge genomic and molecular approaches to understand antibiotic resistance. Key themes include the genetic basis of resistance phenotypes, the spread of resistant clones in regional settings, and novel strategies to combat bacterial invasion. The long-standing interest in antibiotic pharmacokinetics is evident from his earlier work on ciprofloxacin in sweat (1995), which laid groundwork for current studies on antibiotic efficacy in specific body compartments.

Dr. Kemp collaborates extensively within the Danish clinical microbiology network, as evidenced by multi-institutional studies involving Region Zealand and the University of Copenhagen. His work often involves national and international consortia focusing on surveillance and molecular characterization of resistant pathogens.